ADORA2A and neoplasm: For myeloid cells, ADO enhances immunosuppressive activity of MDSCs through A2AR/A2BR via both the STAT3 and CREB signaling pathways, and contributes to tumor tissue remodeling and immunosuppressive microenvironment construction (52, 53).